Protocol Analyzer - POSTED 06/10/07
If you aren’t using Protocol Analyzer, you should be. Here are the dates of some upcoming webcasts…..
Thursdays, June 21 and 28 at 3PM EDT
For the web portion: www.readytalk.com with participant access code 6986896
For the audio portion 1-866-740-1260 with access code 6986896
Introduction to Oncology Pharmaceutical Services - NEW 06/19/07
Think you can't improve the financial outlook of your oncology practice while enhancing patient care? You can -- by tapping into the right knowloedge and support.
Speaker: Forest Britt, Regional Director, Oncology Pharmaceutical Services
Topic: Introduction to Oncology Pharmaceutical Services
Dates: Wednesday June 27, 2007 at 12:00pm PST
Click here for more information >>
Prostate Cancer Research Institute - NEW 06/19/07
The Prostate Cancer Research Institute, an organization dedicated to educating Prostate Cancer patients and their families, is proud to announce the 2007 National Conference on Prostate Cancer, taking place Friday, September 7 through Sunday, September 9, 2007 at the LAX Marriott Hotel. www.pcri.org.
Download the brochure and registration information packet >>

Medicare Releases Final PQRI Details - POSTED 06/10/07
The Centers for Medicare & Medicaid Services (CMS) this week released the final specifications for its Physicians Quality Reporting Initiative (PQRI), which starts July 1. The specifications contain descriptions and clinical recommendation statements for each of the 74 performance measures and include instructions on how to code each measure’s numerator and denominator. (182 pages)

PQRI Coding For Quality Handbook - NEW 06/19/07
CMS has released the handbook for the PQRI initiative. It can be found here >>

ASCO's National Audioconference on PQRI - NEW 06/19/07
ASCO hosted a national audioconference on Medicare's Physician Quality Reporting Initiative (PQRI).
Links to access the call materials are provided below:
Call Materials
ASCO PQRI slide presentation (pdf version)
2007 PQRI Measures for Consideration by Oncology Providers

Discarded Drugs & Biologicals - UPDATED 06/19/07
CMS Change Request 5520, revises the Medicare Claims Processing Manual , Chapter 17, Sections 40 and 100.2.9 to include language clarifying that Medicare will cover the amount of a single use vial or single use package of a drug or biological that was discarded along with the amount of that single use vial/package that was administered to the Medicare patient up to the amount of the drug or biological as indicated on the vial or package label. CMS expects that physicians will make good faith efforts to limit wasted drug. CMS will not pay for drug that must be discarded when an appropriate vial size that would eliminate waste is available but not ordered. Reporting discarded drug with modifier -JW, “Drug or Biological Amount Discarded/Not Administered to Any Patient”, may be required by your Medicare contractor. Watch for updates on this in your Medicare carrier’s newsletters/bulletins.
Resources:
CMS MLN Matters Number 5520
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5520.pdf
CMS Transmittal 1248 Change Request 5520
http://www.cms.hhs.gov/transmittals/downloads/R1248CP.pdf
Deadline Approaches for New CMS 1500 Form - UPDATED 06/19/07
The Centers for Medicare & Medicaid Services (CMS) announces in Change Request 5616 , that Medicare contractors will no longer accept CMS-1500 Claim Form version (12-90) after July 1, 2007. The only acceptable claim form will be the CMS-1500 Claim Form version (08-05). Go to the National Uniform Claim Committee Website for more information, instructions and FAQs & to view the new 1500 08/05 form.
Resources:
CMS “Breaking News” Article on 1500 08/05
http://www.cms.hhs.gov/ElectronicBillingEDITrans/Downloads/Webterminateold1500.pdf
CMS Transmittal 1247 Change Request 5616
http://www.cms.hhs.gov/transmittals/downloads/R1247CP.pdf
CMS MLN Matters Number 5616
http://www.cms.hhs.gov/MLNMattersArticles/downloads/MM5616.pdf
National Uniform Claim Committee
http://www.nucc.org/
CMS Discontinues UPIN Assignment - POSTED 06/10/07
The CMS will discontinue assigning Unique Physician Identification Numbers (UPIN) on June 29, 2007, but CMS will maintain its UPIN public "look-up" functionality and Registry website (http://www.upinregistry.com) through September 30, 2007. (CR 5584)

NPI Look-Up Tool Available Soon - POSTED 06/10/07
So, you’ve gotten your National Provider Identifier (NPI), right? Did you know you will also have to include the NPIs of referring physicians and health care facilities on your claim forms?
The Centers for Medicare & Medicaid Services (CMS) finally announced that physicians and other covered entities will soon be able to look up NPIs by simply entering the provider or facility name into an online database. This online lookup will be available on June 28, 30-days after CMS’s official NPI data dissemination policy was published in the Federal Register.
The online lookup will return NPIs and relevant demographic information, but it will not disclose social security numbers, dates of birth, or IRS taxpayer identification numbers, according to CMS. 
New Immune Globulin Codes - UPDATED 06/19/07
Effective for claims with dates of service on or after July 1, 2007, HCPCS code J1567 (injection, immune globulin, intravenous, non-lyophilized (e.g. liquid), 500 mg) will no longer be payable for Medicare.
In its place, the following HCPCS codes will be payable, effective July 1, 2007:
• Q4087 Octagam Injection, intravenous, non-lyophilized (e.g. liquid), 500 mg
• Q4088 Gammagard Liquid Injection, intravenous, non-lyophilized (e.g. liquid), 500 mg
• Q4090 HepaGam B Injection, intramuscular, 0.5 ml when given intravenously bill using an appropriate Not Otherwise Classified (NOC) code in the absence of a specific HCPCS code.
• Q4091 Flebogamma Injection, intravenous, non-lyophilized (e.g. liquid), 500mg
• Q4092 Gamunex Injection, intravenous, non-lyophilized (e.g. liquid), 500 mg
• Q4089 Rhophylac injection, intramuscular or intravenous, 100iu
Remember: These changes are specific to Medicare.
Resources:
CMS Transmittal 1261 Change Request 5635
http://www.cms.hhs.gov/transmittals/downloads/R1261CP.pdf
MLN Matters Article
MM5635.pdf
MOASC Submits Comments to Medicare Regarding ESA Policy - NEW 06/19/07
Dr. Cary Presant, MOASC Chairman of the Board, responds to the new ESA policy.

Special J-Code Review Offer for MOASC Members - NEW 06/19/07
Leaverage the expertise of an oncology consultant pharmacist and enhance your practice performance. By working with Oncology Pharmaceutical Services, you can benefit from an on-site consultant pharmacist, powerful network drug contracting and related services.
To make arrangements for this J-Code Review offer please call Randy Harken at (310)-694-6871 or email at randy.harken@usoncology.com
|